Higher ultra-processed food intake raises the risk of inflammatory bowel disease (PURE study: HR 1.82 for >=5 servings/day).
Original statement
ارتبط استهلاك خمس حصص يومياً أو أكثر من الأطعمة فائقة المعالجة بخطر أعلى لأمراض الأمعاء الالتهابية (HR 1.82)
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Higher ultra-processed food intake raises the risk of inflammatory bowel disease (PURE study: HR 1.82 for >=5 servings/day).
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (study selection and narrative are the archive's, not necessarily Elawady's)
- Origin
- https://eltayebat.com/rule/ultra-processed-foods/
- Attribution uncertainty
- The archive homepage states that the forbidden-food section is supported by research 'independently of Dr. Diaa's words'. No evidence was found that Elawady himself cited these studies.
- Claimed mechanism
Emulsifiers, additives (hypothesised).
- Claimed health effect
Crohn's disease, ulcerative colitis.
- Population concerned
Adults 35-70, 21 countries
- Geographic restriction by Elawady
none found
Scientific assessment
Potentially true – Some evidence points in favour of the statement, but it is not sufficient for a clear judgement.
Certainty of evidence: low – Further research is likely to change the assessment considerably.
1. What was claimed?
UPF raises IBD risk.
2. What is demonstrably correct?
Narula 2021 (A-UPF-12): HR 1.82 (1.22-2.72) for >=5 servings/day vs <1; soft drinks, refined sweetened foods, salty snacks and processed meat each associated.
3. What is wrong or exaggerated?
Absolute risk is low (467 cases among 116,087 over ~10 years); single cohort with low precision and risk of outcome misclassification; the ulcerative colitis association was not significant, and pooled evidence is weak for Crohn's disease and absent for ulcerative colitis (A-UPF-13).
4. What remains unclear?
Which components matter.
5. Which studies support it?
6. Which studies contradict it?
A-UPF-13 (limiting: Crohn's disease class IV, HR 1.71; ulcerative colitis class V, HR 1.17, 0.86-1.61).
7. What applies to Germany and Europe?
Applies.
8. What is known about Egypt?
PURE included Middle Eastern sites; country-level results not reviewed.
9. What practical conclusion is appropriate?
Association noted; IBD is multifactorial.
Assessment details
- Rationale for certainty of evidence
One large multinational cohort (467 IBD cases); IBD was self-reported with only about 20% of diagnoses validated, ulcerative colitis (377 of 467 cases) was not significantly associated at >=5 servings/day (HR 1.46, 0.93-2.28), and there was no gradient between 1-4 and >=5 servings/day (A-UPF-12). The umbrella review grades UPF-Crohn's disease evidence as weak (class IV) and UPF-ulcerative colitis as no evidence (class V) (A-UPF-13). Mechanistic support from animal emulsifier studies; observational.
- Source quality
Accurately reported.
- Regional transferability
Moderate; PURE included Europe, Middle East and other regions.
- Individual exceptions
Not applicable.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 25 October 2026 provisional
In plain language
A large study across 21 countries found more inflammatory bowel disease among people eating the most ultra-processed food. The disease remained rare overall. The finding needs confirmation.
Studies on this claim
Studies supporting the claim (1)
-
Ultra-processed food and inflammatory bowel disease in 21 countries
Narula N et al.. BMJ 2021 · PMID 34261638 · DOI 10.1136/bmj.n1554Cohort studycited by the Tayebat archivefull text checked★ key studyFive or more servings a day: 82% higher IBD risk; legumes, dairy and vegetables showed no link.
Also found no association of dairy, legumes, fruit and vegetables with IBD (relevant to other system rules).
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Is UPF intake associated with IBD?
- How was the study done?
Prospective multinational cohort (PURE), country-specific FFQs.
- How many people, animals or samples were studied?
116,087; 467 IBD cases; Adults 35-70
- What was actually found?
>=5 servings/day HR 1.82 (1.22-2.72); 1-4/day 1.67 (1.18-2.37); soft drinks, refined sweetened foods, salty snacks, processed meat each associated; meat, dairy, starch, fruit, vegetables, legumes not associated.
- How large was the observed effect?
HR 1.82 (1.22-2.72)
- What do the results mean in everyday life?
Association; IBD remains rare.
- What are the study's limitations?
Only 467 cases; most diagnoses were self-reported and only about one in five checked against medical records; diet measured once; the higher risk was similar at 1-4 and at 5 or more servings per day.
- What does it say about Elawady's specific claim?
Supports C-UPF-05.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
It cannot prove that ultra-processed food causes IBD or which ingredient might be responsible.
No study in this group is marked as key.
Studies contradicting or limiting the claim (1)
-
Umbrella review: ultra-processed food and health
Lane MM et al.. BMJ 2024 · PMID 38418082 · DOI 10.1136/bmj-2023-077310Systematic reviewcited by the Tayebat archivefull text checked★ key studyUPF was linked to 32 of 45 health outcomes; certainty was mostly low.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What is the credibility of associations between UPF and health outcomes?
- How was the study done?
Umbrella review of 45 pooled analyses with credibility classes and GRADE.
- How many people, animals or samples were studied?
45 pooled analyses; n=9,888,373; Pooled populations
- What was actually found?
Class I: CVD mortality RR 1.50 (1.37-1.63; GRADE very low); T2D dose-response RR 1.12 (1.11-1.13; moderate); prevalent anxiety OR 1.48 (low); common mental disorders OR 1.53 (low). Class II: all-cause mortality RR 1.21 (low), heart-disease mortality HR 1.66 (low), T2D OR 1.40 (very low), depression HR 1.22 (low), sleep OR 1.41, wheezing RR 1.40, obesity OR 1.55 (low). GRADE overall: 22 low, 19 very low, 4 moderate.
- How large was the observed effect?
CVD mortality RR 1.50; T2D 1.12 per dose
- What do the results mean in everyday life?
Consistent links, low certainty.
- What are the study's limitations?
All the studies behind it are observational; many results rest on only 2-4 studies; for most outcomes the certainty is low or very low; the mental-health results come mainly from one-time surveys that cannot show what came first.
- What does it say about Elawady's specific claim?
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Causation.
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
Emulsifiers and gut inflammation in mice
Chassaing B et al.. Nature 2015 · PMID 25731162 · DOI 10.1038/nature14232Animal studycited by the Tayebat archivefull text checked★ key studyTwo common emulsifiers caused gut inflammation and metabolic problems in mice.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Do emulsifiers promote gut inflammation and metabolic syndrome via microbiota?
- How was the study done?
Mouse experiments with emulsifiers, germ-free mice and faecal transplants.
- How many people, animals or samples were studied?
Not stated; Wild-type and colitis-prone mice
- What was actually found?
Emulsifiers induced low-grade inflammation and obesity/metabolic syndrome in wild-type mice and robust colitis in predisposed mice; microbiota encroachment; effects transferable via microbiota.
- How large was the observed effect?
Not applicable
- What do the results mean in everyday life?
Possible concern for humans, not proven.
- What are the study's limitations?
Mouse study only; doses of 0.1-1% in all food or water; the researchers knew which mice got which treatment; some groups very small; only two emulsifiers tested.
- What does it say about Elawady's specific claim?
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
It cannot show that emulsifiers cause bowel inflammation or weight gain in humans, or at what human intake level any effect would occur.
No study in this group is marked as key.
Regional context
Germany / EU
Applies.
Egypt
PURE included Middle Eastern sites; country-level results not reviewed.
What applies in my country?
General scientific assessment
Potentially true A plausible association from one large cohort.
The following areas of food safety are relevant to this statement:
- Additives and processing
- Controls, imports, recalls, labelling
Choose a country to see the checked information for it.
Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.
Country of residence or purchase Compare with another country
References
- Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study.. Narula N et al.. BMJ 2021 · PMID 34261638 · DOI 10.1136/bmj.n1554
- Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.. Lane MM et al.. BMJ 2024 · PMID 38418082 · DOI 10.1136/bmj-2023-077310
- Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.. Chassaing B et al.. Nature 2015 · PMID 25731162 · DOI 10.1038/nature14232